RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP was delisted on the 20th of October, 2023.
3 hedge funds and large institutions have $613 invested in RVL Pharmaceuticals plc Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 31 closing their positions.
91% less funds holding
Funds holding: 32 → 3 (-29)
94% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 31
100% less capital invested
Capital invested by funds: $1.57M → $613 (-$1.57M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.9K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.35K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$523 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Athyrium Capital Management
New York
|
-$1.26M |
| 2 |
Renaissance Technologies
New York
|
-$93K |
| 3 |
Blackstone Inc
New York
|
-$56.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$26.6K |
| 5 |
Millennium Management
New York
|
-$23.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCBT
26
Dakota Community Bank & Trust
Hebron,
North Dakota
| – | -$157 | -1,809 | Closed |
|
27
Bank of America
Charlotte,
North Carolina
| – | -$148 | -1,720 | Closed |
|
28
Osaic Holdings
Scottsdale,
Arizona
| – | -$103 | -1,187 | Closed |
|
29
Fidelity Investments
Boston,
Massachusetts
| – | -$43 | -500 | Closed |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$4 | -50 | Closed |
|
|
31
Simplex Trading
Chicago,
Illinois
| – | +$523 | +5,278 | +325% |
|
RVLP Hedge Fund Activity: Q4 2023 in Review
3 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q4 2023, worth a combined $613 — down 100% from $1.57M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of RVLP and 2 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $17.9K. The largest seller was Athyrium Capital Management, exiting entirely with an estimated $1.26M sold.
- 3 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q4 2023, down from 32 in Q3 2023.
- Funds reported $613 of RVL Pharmaceuticals plc Ordinary Shares stock for Q4 2023, down 100% quarter-over-quarter.
- 2 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q4 2023 and 31 closed out, a net change of -29 holders.
- The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q4 2023 was XTX Topco, an estimated $17.9K added.
- The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q4 2023 was Athyrium Capital Management, an estimated $1.26M sold.
Based on aggregated 13F filings for Q4 2023.